1-甲基-3-苯基-1H-吡唑-5-羧酸乙酯 | 10250-63-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 1-甲基-3-苯基-1H-吡唑-5-羧酸乙酯
• 中文别名: 2-甲基-5-苯基-2H-吡唑-3-甲酸乙酯
• 英文名称: 1-methyl-3-phenyl-1H-prazole-5-carboxylic acid ethyl ester
• 英文别名: 2-methyl-5-phenyl-pyrazole-3-carboxylic acid ethyl ester；ethyl 1-methyl-3-phenyl-1H-pyrazole-5-carboxylate；ethyl 1-methyl-5-phenyl-1H-pyrazole-3-carboxylate；ethyl 2-methyl-5-phenyl-2H-pyrazole-3-carboxylate；2-methyl-5-phenyl-2H-pyrazole-3-carboxylic acid ethyl ester；2-Methyl-5-phenyl-2H-pyrazol-3-carbonsaeure-aethylester；ethyl 2-methyl-5-phenylpyrazole-3-carboxylate
• CAS: 10250-63-2
• 化学式: C₁₃H₁₄N₂O₂
• 分子量: 230.266
• InChiKey: JDJQHVJXMXXKFO-UHFFFAOYSA-N

物化性质

• 熔点：
  27 °C
• 沸点：
  380.6±30.0 °C(Predicted)
• 密度：
  1.13±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  44.1
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2933199090
• 危险品标志：
  Harmful
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302
• 储存条件：
  室温且干燥

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Ethyl 1-Methyl-3-phenylpyrazole-5-carboxylate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Ethyl 1-Methyl-3-phenylpyrazole-5-carboxylate
CAS number: 10250-63-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C13H14N2O2
Molecular weight: 230.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-甲基-3-苯基-1H-吡唑-5-羧酸乙酯 在 氢氧化钾 作用下， 以 乙醇 、 水 为溶剂， 反应 6.0h， 生成 2-甲基-5-苯基-2H-吡唑-3-甲酸
  参考文献：
  名称：

  [EN] ANTIBACTERIAL BENZOIC ACID DERIVATIVES
  [FR] DERIVES D'ACIDES BENZOIQUES ANTIBACTERIENS

  摘要：

  这项发明提供了抗菌剂和使用这些剂进行哺乳动物的消毒、卫生、防腐、消毒和治疗感染的方法。

  公开号：

  WO2004018428A1
• 作为产物：
  描述：

  4-苯基-2,4-二氧丁酸乙酯 在 sodium hydride 、 一水合肼 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 、 mineral oil 为溶剂， 反应 2.75h， 生成 1-甲基-3-苯基-1H-吡唑-5-羧酸乙酯
  参考文献：
  名称：

  Discovery of a High Affinity Adenosine A₁/A₃ Receptor Antagonist with a Novel 7-Amino-pyrazolo[3,4-d]pyridazine Scaffold

  摘要：

  DOI：

  10.1021/acsmedchemlett.2c00052

文献信息

• [EN] C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION<br/>[FR] DÉGRONIMÈRES DE TYPE GLUTARIMIDE LIÉS AU CARBONE C3 POUR LA DÉGRADATION DE PROTÉINES CIBLES
  申请人：C4 THERAPEUTICS INC

  公开号：WO2017197046A1

  公开（公告）日：2017-11-16

  This invention provides Degronimers that have carbon-linked E3 Ubiquitin Ligase targeting moieties (Degrons), which can be linked to a targeting ligand for a protein that has been selected for in vivo degradation, and methods of use and compositions thereof as well as methods for their preparation.

  这项发明提供了一种Degronimers，它具有碳连接的E3泛素连接酶靶向基团（Degrons），可以与一个靶向配体相连，该配体针对的是在体内被选为降解的蛋白质，以及它们的使用方法和组成，以及它们的制备方法。
• FIVE-MEMBERED HETEROCYCLIC AMIDES WNT PATHWAY INHIBITOR
  申请人：SUZHOU SINOVENT PHARMACEUTICALS CO., LTD.

  公开号：US20180271846A1

  公开（公告）日：2018-09-27

  The present invention discloses a five-membered heterocyclic amide WNT pathway inhibitor, which belongs to a compound that regulates the activity of a Wnt signaling pathway, and provides a method for preparing such a compound, and the use of such a compound in preparing a medicament that antagonizes the Wnt signaling pathway. The five-membered heterocyclic amide WNT pathway inhibitor provided by the invention has a remarkable anti-tumor activity based on a target-based rational drug design of, and can be used for the development of a new generation of Wnt pathway inhibitors, and has a great clinical application value and considerable market potential.

  本发明公开了一种五元杂环酰胺WNT通路抑制剂，属于调节Wnt信号通路活性的化合物，并提供了制备这种化合物的方法，以及在制备对抗Wnt信号通路的药物中使用这种化合物的用途。本发明提供的五元杂环酰胺WNT通路抑制剂基于靶向合理药物设计具有显著的抗肿瘤活性，可用于新一代Wnt通路抑制剂的开发，并具有巨大的临床应用价值和相当大的市场潜力。
• New Pyrazolium-carboxylates as Structural Analogues of the Pseudo-Cross-Conjugated Betainic Alkaloid Nigellicine
  作者：Andreas Schmidt、Tobias Habeck、Markus Karl Kindermann、Martin Nieger

  DOI：10.1021/jo0344337

  日期：2003.7.1

  Pyrazolium-3-carboxylates were examined as relatives of the betainic alkaloid Nigellicine and as new examples of the sparsely populated class 16 of heterocyclic pseudo-cross-conjugated mesomeric betaines (PCCMB). The title compounds were prepared in a 4-step procedure starting from beta-diketo compounds 8 which were cyclized with substituted hydrazines. The resulting isomeric pyrazole esters 9 and

  研究了3-羧酸吡唑鎓盐作为甜菜碱生物碱Nigellicine的亲缘关系，以及稀疏填充的16类杂环伪交叉共轭中观甜菜碱（PCCMB）的新实例。标题化合物是从β-二酮化合物8开始的4步过程中制备的，这些化合物是用取代的肼环化的。分离所得的异构体吡唑酯9和10，随后在硝基苯存在下用硫酸二甲酯季铵化成吡唑鎓酯11和12。在稀硫酸中皂化效果最好，这导致了假交叉共轭的mesomeric的形成。一步就能将13和14固定在一起。质子化为相应的羧酸需要在二氯甲烷中用四氟硼酸处理甜菜碱。负溶剂变色的作用证明了分子在基态下的电荷分离。进行了X射线晶体学分析，半经验计算和ESI质谱测量，以了解有关伪交叉共轭现象的知识。
• N-&lsqb;(substituted five-membered di- or triaza diunsaturated ring)carbonyl&rsqb; guanidine derivatives for the treatment of ischemia
  申请人：Pfizer, Inc.

  公开号：US06492401B1

  公开（公告）日：2002-12-10

  NHE-1 inhibitors, methods of using such NHE-1 inhibitors and pharmaceutical compositions containing such NHE-1 inhibitors. The NHE-1 inhibitors are useful for the reduction of tissue damage resulting from tissue ischemia.

  NHE-1抑制剂，使用这种NHE-1抑制剂的方法以及含有这种NHE-1抑制剂的药物组合物。这些NHE-1抑制剂对于减少组织缺血引起的组织损伤是有用的。
• Palladium-catalyzed multi-acetoxylation of 1,3-disubstituted 1H-pyrazole-5-carboxylates via direct C(sp2)H or C(sp3)H bond activation
  作者：Jun Ding、Ying Guo、Ling-Yan Shao、Fei-Yi Zhao、Dao-Hua Liao、Hong-Wei Liu、Ya-Fei Ji

  DOI：10.1016/j.cclet.2016.04.007

  日期：2016.10

  1,3-disubstituted 1 H -pyrazole-5-carboxylate derivatives containing multiple potential reactive sites is described. Therein, the sequence of this process has been appropriately investigated. The protocol mainly provides the di- and tri-acetoxylated products for 1,3-diarylpyrazoles. Besides, it is found that the acetoxylation of C(sp 3 ) H bond is prior to that of C(sp 2 ) H bond under structurally

  摘要描述了钯催化的含多个潜在反应位点的1,3-二取代的1 H-吡唑-5-羧酸酯衍生物的多乙酰氧基化反应。其中，已经适当地研究了该过程的顺序。该协议主要提供1,3-二芳基吡唑的二乙酰氧基化产物和三乙酰氧基化产物。此外，发现在结构竞争性条件下，C（sp 3）H键的乙酰氧基化作用优先于C（sp 2）H键的乙酰化作用。